[ad_1]
By a vote of 6-4, the agency’s group of independent counselors concluded that the results of another clinical trial were necessary to evaluate whether the treatment, called AMX0035, would help patients.
[ad_2]
Source link
New ALS Treatment, AMX0035, No Evidence of Benefit, FDA Panel
